Reference: De Maayer, T. (2022). How do you manage to come to work every day, fail at your job of ensuring basic healthcare for the people you serve and still sleep at night? DM168. Summary: In a poignant open letter, Dr Tim De Maayer, a paediatrician at Rahima Moosa Mother and Child Hospital, sheds light […]
Reference: Kamber Zaidi, A., & Dehgani-Mobaraki, P. (2021). The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article. The Journal of Antibiotics, 74(7), 441-454. https://doi.org/10.1038/s41429-021-00430-5 Summary: This review article examines the potential of Ivermectin as a therapeutic agent against SARS-CoV-2 amidst the COVID-19 pandemic. It highlights Ivermectin’s mechanism of action, including its
Reference: Chetty, S. (2021). Dr Chetty’s 8th day therapy for COVID-19. Covexit. Retrieved from [URL] Summary: Dr Shankara Chetty’s 8th Day Therapy for COVID-19 addresses the inflammatory phase occurring after Day 8 of infection, aiming to prevent severe disease progression. The document outlines four key interventions starting at this critical juncture. First, corticosteroids like Prednisone
Reference: FLCCC Alliance. (2021). I-MASS protocol. Retrieved from https://flccc.net/covid-19-protocols/ Summary: The I-MASS protocol, developed by the Front Line COVID-19 Critical Care Alliance (FLCCC), outlines prevention and treatment strategies for COVID-19, particularly focusing on home treatment and mass distribution during outbreaks. For prevention, adults over 18 years are advised to take Ivermectin (18 mg weekly), Vitamin
Reference: Shinde, V., Bhikha, S., Hoosain, Z., Archary, M., Bhorat, Q., Fairlie, L., … & Madhi, S. A. (2021). Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant. The New England Journal of Medicine, 384(20), 1899-1909. https://doi.org/10.1056/NEJMoa2103055 Summary: The NVX-CoV2373 nanoparticle vaccine was evaluated in a phase 2 trial in South Africa during the B.1.351